The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Targeting natural killer cells and natural killer T cells in cancer
Open accessAbstract
Natural killer (NK) cells and natural killer T (NKT) cells are subsets of lymphocytes that share some phenotypical and functional similarities. Both cell types can rapidly respond to the presence of tumour cells and participate in antitumour immune responses. This has prompted interest in the development of innovative cancer therapies that are based on the manipulation of NK and NKT cells. Recent studies have highlighted how the immune reactivity of NK and NKT cells is shaped by the environment in which they develop. The rational use of these cells in cancer immunotherapies awaits a better understanding of their effector functions, migratory patterns and survival properties in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
NK Cell Activating Receptors and Tumor Recognition in Humans
Bottino, C., Moretta, L., & Moretta, A. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_9 · Cited by 77
Schümann, J., Voyle, R. B., Wei, B., & MacDonald, H. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.5815 · Cited by 74
Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo
Sola, C., André, P., Lemmers, C., Fuséri, N., Bonnafous, C., Bléry, M., Wagtmann, N. R., Romagné, F., Vivier, É., & Ugolini, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901653106 · Cited by 73
Self-citationG-protein-coupled receptors in control of natural killer cell migration
Walzer, T., & Vivier, É. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.002 · Cited by 71
iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells
Bellone, M., Ceccon, M., Grioni, M., Jachetti, E., Calcinotto, A., Napolitano, A., Freschi, M., Casorati, G., & Dellabona, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008646 · Cited by 71
Kim, S., Lalani, S., Parekh, V. V., Vincent, T. L., Wu, L., & Kaer, L. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33071 · Cited by 71
Diverse Endogenous Antigens for Mouse NKT Cells: Self-Antigens That Are Not Glycosphingolipids
Pei, B., Speak, A. O., Shepherd, D., Butters, T. D., Cerundolo, V., Platt, F. M., & Kronenberg, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001008 · Cited by 68
Dunbar, E. M., Buzzeo, M. P., Levine, J. B., Schold, J. D., Meier-Kriesche, H.-U., & Reddy, V. S. (2008) · Haematologica · doi:10.3324/haematol.13033 · Cited by 64
Schneiders, F. L., de Bruin, R. C. G., van den Eertwegh, A. J. M., Scheper, R. J., Leemans, C. R., Brakenhoff, R. H., Langendijk, J. A., Verheul, H. M. W., de Gruijl, T. D., Molling, J. W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8819 · Cited by 62
Park, S., Kyin, T., Bendelac, A. S., & Carnaud, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1197 · Cited by 61
Bukowski, J. F., Biron, C. A., & Welsh, R. M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.991 · Cited by 59
Natural killer cell-based therapies
Romagné, F., & Vivier, É. (2011) · F1000 Medicine Reports · doi:10.3410/m3-9 · Cited by 46
Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy.
Miller, J. S., Klingsporn, S., Lund, J., Perry, E. H., Verfaillie, C. M., & McGlave, P. B. (1994) · PubMed · Cited by 42
KIR matching in hematopoietic stem cell transplantation
Bignon, J., & Gagne, K. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.014 · Cited by 41
Cutting Edge: IFN-γ Signaling to Macrophages Is Required for Optimal Vα14i NK T/NK Cell Cross-Talk
Wesley, J. D., Robbins, S. H., Sidobre, S., Kronenberg, M., Terrizzi, S. C., & Brossay, L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3864 · Cited by 39
Self-citationAlici, E. (2010) · PubMed · Cited by 35
Synthetic iNKT cell-agonists as vaccine adjuvants — finding the balance
Cerundolo, V., Barral, P., & Batista, F. D. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.003 · Cited by 33
CD1d Activation and Blockade: A New Antitumor Strategy
Teng, M. W. L., Yue, S. C., Sharkey, J., Exley, M. A., & Smyth, M. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802964 · Cited by 30
Kammertoens, T., Qin, Z., Briesemeister, D., Bendelac, A. S., & Blankenstein, T. J. F. (2011) · International Journal of Cancer · doi:10.1002/ijc.27411 · Cited by 26
Kijima, M., Gardiol, N., & Held, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027639 · Cited by 18
Cited by
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508
Arneth, B. (2019) · Medicina · doi:10.3390/medicina56010015 · Cited by 1,250
André, P., Denis, C., Soulas, C., Bourbon-Caillet, C., Lopez, J., Arnoux, T., Bléry, M., Bonnafous, C., Gauthier, L., Morel, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.014 · Cited by 1,221
Self-citationDai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Metadata
- Authors
- Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L.
- Venue
- Nature Reviews Immunology
- Published
- 2012-03-22
- Volume
- 12
- Issue
- 4
- Pages
- 239-252
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2065202184
- Cited by
- 850
- References
- 220
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.